Bacterial Infections after Renal Transplantation

Nephron

Volumn 75, Issue 2, 1997, Pages 140-153

  Schmaldienst, S ^a   Hort W H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

BACTEREMIA; BACTERIAL INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LUNG INFECTION; PRIORITY JOURNAL; REVIEW; SEPTICEMIA; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 0031059274     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189523     Document Type: Article

References (101)

1. Rubin RH: Infectious disease complications of renal transplantation. Kidney Int 1993:44: 221-236.
2. Gray JR. Kasiske BL: Patient and renal allograft survival in the late posttransplant period. Semin Nephrol 1992:12:343-352.
3. TolkolT-Rubin NE, Cosimi AB. Russell PS. Rubin RH: A controlled study of trimethoprim-sulfamethoxazole prophylaxis in urinary tract infection in renal transplant recipients. Rev Infect Dis 1982:4:614-618.
4. Rcnoult E. Aouragh F. Maycux D. Hestin D, Lataste A, Hubert J. L'Hennite J. Weber M. Kessler M: Factors influencing early urinary tract infections in kidney transplant recipients. Transplant Proc 1994;26:2056-2058.
5. Fox BC, Sollinger HW, Beizer FO, Maki DG: A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: Clinical efficacy, absorption of trimethoprim-sulfamethoxazole. effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990: 89:255-274.
6. Maki DG. Fox BC. Kuntz J. Sollinger HW. Beizer FO: A prospective, randomized, doubleblind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole. interactions with cyclosporine. J Lab Clin Med 1992:119:11-24.
7. Scorza L.B. Waymack JP. Pruitt BA: The effect of transfusions on the incidence of bacterial infection. Milit Med 1990:155:337-339.
8. Francis DMA. d'Apice AJ. Clunie GJA: Wound infections presenting several years after successful renal transplantation. Transplant Proc 1988:20:128-130.
9. Munda R. Hutchins M. First MR. Carey M, Schroeder T. Alexander JW: Infection in OKT3-treated patients receiving additional antirejection therapy. Transplant Proc 1989:21: 1763-1765.
10. Yang CW. Kim YS. Yang KH. Chang YS. Yoon YS. Bank BK: Acute focal bacterial nephritis presented as acute renal failure and hepatic dysfunction in a renal transplant recipient. Am J Nephrol 1994:14:72-75.
11. Rao KV. Andersen RC: Long-term results and complications in renal transplant recipients. Transplantation 1988:45:45-52.
12. Wynn JJ. Pfaff WW, Patton PR. Peterson JC. Salomon DR. Fennell RS, Scomik JC. Howard RJ: Late resultsof renal transplantation. Transplantation 1988:45:329-333.
13. Bravman KL. Stephanian E. Matas AJ. Schmidt W. Payne WD, Sutherland DER. Gores PF. Najarían JS. Dunn DL: Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 1992; 127:38-48.
14. Vincenti F. Amend W, Feduska NJ, Duca RM. Salvatierra O: Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes. Am J Med 1980:69:107-112.
15. Rubin RH. Tolkolff-Rubm NE: The impact of infection on the outcome of transplantation. Transplant Proc 1991;23:2068-2074.
16. Dummcr JS. Hardy A, Poorsattar A. Ho M: Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 1983:36:259-267.
17. Stuby U, Kaiser P. Grafinger P. Biescnbach G. Zazgornik J: Urinary tract infection after renal transplantation under conventional therapy and cyclosporine. Transplant Proc 1989:21: 2110-2111.
18. Sollinger HW. Knechtle SJ, Reed A. D'Ales-sandro AM. Kalayoglu M. Belzer FO Pirsch I' Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. Ann Surg 1991:214:703-711.
19. Mora M. Wilms H. Kirstc G: Significance of bacterial contamination of cadaver donor renal allografts before transplantation. Transplant Proc 1991:23:26–48.
20. Rowinski W. Pacholczyk M. Chmura A. Cajzner S. Lao M. Kowalczyk J, Lagiewska B, Wa-laszewski J: Influence of positive cultures in doner and preservation medium on development of infection in cadaveric kidney transplant recipients. Beneficial effects of antibiotic coverage at the time of nephrectomy. Transplant Proc 1991:23:2656.
21. Warren JW. Platt R. Thomas RJ. Rosner B, Kass EH: Antibiotic irrigation and catheter-associated urinary tract infections. N Engl.J Med 1978;299:570-573.
22. Segalowsky AI. Ransler CW. Peters PC. Dickerman RM. Gailiunas P. Helderman JH. Hull AR. Atkins C: Urologie complications in 505 renal transplants with early catheter removal. J Urol 1983;129:929-932.
23. Goodman CM, Hargeave TB: Survey of antibiotic prophylaxis in European renal transplantation practice. Int Urol Nephrol 1990:22:173-179.
24. Rayner BL. Cassidy MJ. Jacobsen JE. Pascoc MD, Pontin AR. van Zvl Snnt R: Is preliminary bincphrectomy necessary' in patients with autosomal-dominant polycystic kidney disease undergoing renal transplantation. Clin Nephrol 1990:34:122-124.
25. Bcnnct WM. Elzinga LW: Clinical management of autosomal-dominant polycystic kidney disease. Kidney Int 1993:42:S74-S79.
26. Wetzel O, Hormi M. Le Normand L, Karani G. Gucnel J. Auvigne J: Autosomal-dominant polycystic kidney disease: Urologie complications and results of kidney transplant. Prog Urol 1993:3:252-262.
27. Fitzpatrick PM. Torres VE, Charboncau JW. Offord KP. Holley KE. Zinckc H: Long-term outcome of renal transplantation in autosomal-dominant polycystic kidney disease. Am J Kidney Dis 1990:15:535-543.
28. Williams G, Mitclicson I ID, Castro JE: Transplantation for polycystic kidney disease. Urology 1978;12:628-630.
29. TolkolT-Ruhin NE, Rubin RH: Opportunistic fungal and bacterial infections in the renal transplant recipient. J Am Soc Nephrol 1992:2: S264-S269.
30. Sumrani NB. Delaney V. Ding ZL. Davis R. Daskalakis P. Friedman EA. Butt KM. Hong JH: Diabetes mellitus after renal transplantation in the cyclosporine era-An analysis of risk factors. Transplantation 1991:51:343-347.
31. Davenport A. Davison AM. Will EJ. Newton KE. Toothill C: Aluminium mobilization following renal transplantation and possible effect on susceptibility to bacterial sepsis. J Med 1991:79:407-423.
32. Grino JM. Castelao AM. Seron D. Gonzalez C. Galceran JM. Gil-Vemet S. Andres E. Mestrc M. Torras J. Alsina J: Antilymphocyte globulin versus OKT3 induction therapy in cadaveric kidney transplantation: A prospective randomized study. Am J Kidney Dis 1992:20:603-610.
33. Rubin RH. Wolfson JS. Cosimi AB. Tolkoff-Rubin NE: Infection in the renal transplant recipient. Am J Med 1981:70:405-411.
34. Prat V. Horcickova M. Matousovic K. llatala M. Liska M: Urinary tract infection in renal transplant patients. Infection 1985;13:207-210.
35. Grckas D. Thanos V. Dioudis C. Alivanis P. Tourkantonis A: Treatment of urinary tract infections with ciprofloxacin after renal transplantation. Int J Clin Pharmacol Thcr Toxicol 1993:31:309-311.
36. Hess B, Metzger RM, Ackermann D. Montan-don A. Jaeger P: Infection-induced stone formation in a renal allograft. Am J Kidney Dis 1994:24:868-872.
37. Kcntouni-Noly JC. Cloix P. Martin M. Rabo-donirina M. Lefrançois N. Sepetjan M: Analysis of nosocomial infections in the renal and pancreas transplant recipients. Transplant Proc 1994;26:284.
38. Granger DK. Burd RS, Schmidt WJ. Dunn DL. Matas AJ: Incidence and timing of infections in pediatric renal transplant recipients in the cyclosporine era. Transplant Proc 1994:26:64.
39. Alexopoulos E, Memmos D. Sakellariou G. Paschalidou E, Kyrou A. Papadimitriou M: Urinary tract infections after renal transplantation. Drugs Exp Clin Res 1985:11:101-105.
40. Capocasale E. Mazzoni MP. Tondo S. D'Errico G: Antimicrobial prophylaxis with ceftriaxone in renal transplantation. Chemotherapy 1994; 40:435-440.
41. Rubin RH. Tolkoff-Rubin NE: Antimicrobial strategies in the care of organ transplant recipients. Antimicrob Agents Chemother 1993:37: 619-624.
42. Kovle MA. Ward HJ. Twomev PA. Glassock RF. Rajfer J: Declining incidence of wound infection in cadaveric renal transplant recipient. Urology 1988;31:103-106.
43. Gottesdiener KM: Transplanted infections: Donor-to-host transmission with the allograft. Ann Intern Med 1989:110:1001-1016.
44. Lai MK, Huang CC. Chu SH, Chuang CK, Chen HW. Chen CS: Surgical complications in renal transplantation. Transplant Proc 1994: 26:2165-2166.
45. Lapchik MS, Filho AC. Pestana JAO, Filho APS. Wey SB: Risk factors for nosocomial urinary tract and postoperative wound infections in renal transplant patients: A matched-pair case-control study. J Urol Nephrol 1992:147: 994-998.
46. Tillegard A: Renal transplant wound infection: The value of prophylactic antibiotic treatment. Scand J Urol 1984:18:215-221.
47. d'lvemois C. Dupon M. Dartigucs JF. Potaux L. Aparicio M. Lacut JY: Decreased incidence of infection after renal transplantation with the use of cyclosporine. Eur J Clin Microbiol Infect Dis 1991; 10:911-916.
48. Merion RM. Twork AM. Rosenberg I. Ham JM. Burtch GD. Turcotte JG, Rocher LL. Campbell DA Jr: Obesity and renal transplantation. Surg Gynecol Obstet 1991:172:367-376.
49. Tokat Y. Coker A. Basci A, Hoscoskun C. Kaplan H, Yararbas O: Is mezlocilline prophylaxis effective in clinical renal transplantation? Transplant Proc 1992:24:1757.
50. Suthanthiran M. Strom TB: Renal transplantation (review). N Engl J Med 1994:331.
51. Robles NR, Gallego E, Anaya F. Franco A. Val-berrabano F: Antibiotic prophy laxis before kidney transplantation. Enferm Infecc Microbiol Clin 1990;8:74-77.
52. Cohen J, Rees AJ, Williams G: A prospective randomized controlled trial of perioperative antibiotic prophylaxis in renal transplantation. J Hosp Infect 1988:11:357-363.
53. Spielbergcr M. Schmid T. Sandbichlcr P. Pern-thaler H, Bösmüller C. Semenitz E, Margreiter R: Infektiöse Komplikationen in der Frühphase nach Nierentransplantation. Wien Klin Wo-chenschr 1989; 101:238-241.
54. Takahashi K, Yagisawa T. Hiroshi T, Teraoka S. Fuchinoue S, Honda H. Goya N, Tanabe K. Ebihara K. Ooba S: Infectious diseases in kidney transplant recipients treated with cyclosporine. Nippon Hinyokika Gakkai Zasshi 1989: 80:175-184.
55. Hanto DW. Jcndrisak MD. So SK, McCullough CS. Rush TM. Michalski SM. Phelan D. Mohanakumar T: Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Transplantation 1994:57:377-384.
56. Cole EH. Callran DC. Farewell VT. Aprile M. Bear RA. Pei YP, Fenton SS. Tobcr JA, Cardel-la CJ: A comparison of rabbit antithymocyte scrum and OKT3 as prophylaxis against renal allograft rejection. Transplantation 1994:57: 60-67.
57. Oh CS. Stratta RJ. Fox BC. Sollinger HW. Beizer FO. Maki DG: Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation 1988;45:68-73.
58. Toogood GJ, Roakc JA. Morris PJ: The relationship between fever and acute rejection or infection following renal transplantation. Clin Transplant 1994:8:373-377.
59. Indudhara R. Menon M. Khauli RB: Posttransplant Ivmphoccle presenting as ‘acute abdomen’. Am J Nephrol 1994:14:154-156.
60. Hall LMC. Chen HY. Williams RJ: Vancomy-cin-rcsistant Enterococcus durons. Lancet 1992:340:1105.
61. Sastry V. Brennan PJ. Levy MM, Fishman N, Friedman AL. Naji A. Barker CF. Brayman KL: Vancomycin-resistant enterococci: An emerging pathogen in immunosuppressed transplant recipients. Transplant Proc 1995: 27:954-955.
62. Thayer C, Bartlett ST, Ward RE: Increased septic complications with three-drug sequential immunosuppression for cadaver renal transplants. Am J Surg 1990:160:614-617.
63. Bock HA. Gallati H. Zürcher RM. Bachofen M. Mihatsch M. Landmann J. Thiel G: A randomized prospective trial of prophylactic immunosuppression with ATG-Frescnius vs. OKT3 after renal transplantation. Transplantation 1995;59:830-840.
64. lanhez LE. Sampaio M. Chocair PR. Fonseca JA, Sabbaga E: The influence of socio-economic conditions in renal posttransplant infection. Rev Assoc Med Bras 1993:39:33-36.
65. Hollander AAM. van Saase JLCM, Kootte AMM, van Dorp WT, van Bockei HJ. van Es LA. van der Woude FJ: Beneficial effects of conversion from cyclosporin the azathioprine after kidney transplantation. Lancet 1995:345: 610-614.
66. Tarantino A. Aroldi A, Stucchi L, Montagnino G. Mascaretti L. Vegeto A. Ponticelli C: A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation. Transplantation 1991: 52:53-57.
67. Brinker KR. Dickcrman RM, Gonwa TA. Hull AR. Langley JW, Long DL. Nesser DA. Trevino G, Velez RL. Vcrgnc-Marini PJ: A randomized trial comparing double-drug and tripledrug therapy in primary cadaveric renal transplants. Transplantation 1990:50:43-49.
68. Fryer JP, Granger DK. Leventhal JR. Gillingham K. Najarian JS. Matas AJ: Steroid-related complications in the cyclosporine era. Clin Transplant 1994:8:224-229.
69. Stratia RJ. Armbrust MJ, Oh CS, Pusch JD, Kalayoglu M, Sollinger HW. Beizer FO: Withdrawal of steroid Immunsuppression in renal transplant recipients. Transplantation 1988; 45:323-328.
70. Peters DH, Fitton A, Plosker GL, Faulds D: Tacrolimus: A review of its pharmacology, and the therapeutic potential in hepatic and renal transplantation. Drugs 1993;46:746-794.
71. Singh N. Gayowski T, Wagoner M. Yu VL: Infectious complications in liver transplant recipients on tacrolimus. Transplantation 1994; 58:774-778.
72. Kusne S. Martin M. Shapiro R, Jordan M. Fung J. Alessiani M. Jain A, Todo S. Starzl T: Early infections in kidney transplant recipients under FK506. Transplant Proe 1991:23:956-957.
73. Shapiro R. Jordan ML. Scantlebury VP. Vivas C. Fung JJ, McCauley J. Randhawa P. Dcme-tris AJ. Irish W. Mitchell S, Hakala TR. Simmons RL. Starzl TE: A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation 1995:59:485-490.
74. Mayes JT. Thistlcthwaite JR. Stuart JK Jr, Buckingham MR, Stuart FP: Reexposure to OKT3 in renal allograft recipients. Transplantation 1988:45:349-353.
75. Alloway R. Kotb M. Hathaway DK. Gabcr LW, Vera SR. Gabcr AO: Randomized doubleblind study of standard versus low-dose OKT3 induction therapy in renal allograft recipients. Am J Kidney Dis 1993:22:36-43.
76. Stcinmuller DR. Hayes JM. Novick AC, Strccm SB. Hodge E. Slavis S. Marlines A, Gra-ncto D. Pearce G: Comparison of OKT3 with ALG for prophylaxis for patients with acute renal failure after cadaveric renal transplantation Transplantation 1991:52:67-71.
77. Klauser R, Zlabingcr GJ. Traindl O. Franz M. Watschingcr B. Pohanka E. Dulacck S. Kova-rik J: Influence of immunosuppressive therapy on infectious complications in renal transplant recipients. Transplant Proe 1992:24:292-294.
78. Waid TH, Lucas BA. Thompson JS. Brown SA. Munch L. Prebeck RJ. Jezek D: Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in renal allograft recipients. Transplantation 1992:53:80-86.
79. Cantarovich D. Le Mauff B. Hourmant M. Dantal J. Baatard R. Denis M. Jaques Y. Ka-ram G. Paineau J, Soulillou JP: Prevention of acute rejection episodes with an anti-interleukin-2 receptor monoclonal antibody. Transplantation 1994;57:198-203.
80. Hourmant M. Le Mauff B. Cantarovich D. Dantal J. Baatard R. Denis M, Jaques Y. Ka-ram G. Soulillou JP: Prevention of acute rejection episodes with an anti-interlcukin-2 receptor monoclonal antibody. Transplantation 1994;57:204-207.
81. Kckec Y, Tavii S, Tokyay R, Habcral MA: Infections after kidney transplantation. Transplant Proe 1992:24:1932-1933.
82. Rostami M. Askari MA. Shojaian S: Determination of the cause of fever in allograft recipients in West Iran (Bakhtaran). Transplant Proe 1992:24:1935-1937.
83. Steinhoff J. Biihner U. Fedderscn A. Wood WG. Preuss R. Frickc L, Facrbcr P. Dodt C. Hover J, Sack K: C-reaktives Protein im Urin. Dtsch Med Wochenschr 1992:117:894-899.
84. 2-Makroglobulin im Urin. Dtsch Med Wochenschr 1994:119:1-6.
85. Corey HE. Greifer I. Greenstein SM. Tcllis V, Spitzer A: The fractional excretion of urea: A new diagnostic lest for acute renal allograft rejection. Pcdiatr Nephrol 1993:7:268-272.
86. Tsang V. Lui S. Hilson A. Moorhead J. Fernando O. Sweny P: Gallium-67 scintigraphy in the detection of infected polycystic kidneys in renal transplant recipients. Nucl Med Commun 1989:10:167-170.
87. Schmaldienst S, Hörl WH: Bacterial infections during immunosuppression-Immunosuppressive agents interfere not only with immune response, but also with polymorphonuclear cell function. Nephrol Dial Transplant 1996:11: 1243-1245.
88. Pollock CA. Mahony JF. Ibels LS. Caterosn R.I. Waugh DA. Wells JV. Sheil AGR: Immunoglobulin abnormalities in renal transplant recipients. Transplantation 1989:47:952-956.
89. Stevens C. Lempcrt N. Freed BM: The effects of immunosuppressive agents on in vitro production of human immunoglobulins. Transplantation 1991:51:1240-1244.
90. Yoshimura N. Ohmoto Y. Yasui H. Ohsaka Y. Bong JM. Kobayashi Y. Oka T: The direct effect of FK506 and rapamycin on interleukin-1(β) and immunoglobulin production in vitro. Transplantation 1994:57:1815-1818.
91. Cardelia CJ. Weissgarten J. Ng CM. Friedman E: The effect of exogenous lymphokines on immunoglobulin production and lymphocyte proliferation in renal transplant patients. Transplantation 1989:47:300-304.
92. El-Hag A. Clark RA: Immunosuppression by activated human neutrophils. J Immunol 1987:139:2406-2413.
93. Zlabingcr GJ. Rosenkranz AR. Schmaldienst S. Stuhlmeicr K. Böhmig G. Stöckl J. Pohanka E. Kovarik J: Reactive oxygen product formation after Fc-gamma receptor-mediated neutrophil activation by monomeric mouse IgG2a: Implications for the generation of first dose effect after OKT3 treatment. Eur J Immunol 1993;23:977-980.
94. Hörl WH, Wanner C, Riegel W, Schlosser W. Wilms H. Schollmcyer P: Reduction of degranulation of polymorphonuclear leucocytes by immunosuppression in patients following cadaveric renal transplantation. Transplantation 1989:47:144-148.
95. Hcmpelmann U. Haag-Weber M, Hörl WH, Tscheschc H: Effect of immunosuppressive drugs on the release of metalloproteins from human polymorphonuclear leucocytes. Transplant lnt 1991;4:26-30.
96. Riegel W. Leverenz K, Schollmcyer P. Wilms H. Hörl WH: Plasma levels of main granulocyte components during hemodialysis: Effects of immunosuppression. Nephron 1987:46: 161-166.
97. Golshan N. Barker CF, MacGregor RR: Granulocyte function in recipients of renal transplant from live related donors and from cadavers. J Infect Dis 1980:142:876-883.
98. Kharazmi A. Svenson M. Nielsen H. Birgens HS: Effect of cyclosporine A on human neutrophil and monocyte function. Scand J Immunol 1985:21:585-591.
99. Shah SV. Wallin JD, Cruz FC: Impaired oxidative metabolism by leucocytes from renal transplant recipients: A potential mechanism for the increased susceptibility to infections. Clin Nephrol 1984:21:89-92.
100. Kolb G, Eckle I. Bittner K. Müller T. Have-mann K. Lange H: Latent inhibition of granulocyte function by cyclosporine A. Immunobiology 1990;181:22-30.
101. Redl H, Lamache H, Paul E. Schiesscr A. Schlag G: Effect of méthylprednisolone and dexaméthasone on granulocyte function and complement activation. First Vienna Shock Forum, Part B, 1987.